カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のニューロトロフィン市場2022年：神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他

◆英語タイトル：Global Neurotrophins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8903）◆商品コード：GIR22MY8903
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：95
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ニューロトロフィン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニューロトロフィンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニューロトロフィン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他

用途別セグメントは次のように区分されます。
・アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他

世界のニューロトロフィン市場の主要な市場プレーヤーは以下のとおりです。
・Johnson＆Johnson、Lonza Groups、FibroGen、Scil Proteins GmbH、Merck Serono、Scil Proteins GmbH、PeproTech、GE Healthcare

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニューロトロフィン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニューロトロフィンメーカーの企業概要、2019年～2022年までのニューロトロフィンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニューロトロフィンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニューロトロフィンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニューロトロフィンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニューロトロフィン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニューロトロフィンの産業チェーンを掲載しています。
・第13、14、15章では、ニューロトロフィンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson＆Johnson、Lonza Groups、FibroGen、Scil Proteins GmbH、Merck Serono、Scil Proteins GmbH、PeproTech、GE Healthcare
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他
・用途別分析2017年-2028年：アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他
・ニューロトロフィンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニューロトロフィンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニューロトロフィンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニューロトロフィンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニューロトロフィンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Neurotrophins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neurotrophins market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Alzheimer’S Disease accounting for % of the Neurotrophins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nerve Growth Factor segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neurotrophins include Johnson＆Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, and Merck Serono, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neurotrophins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Dehydroepiandrosterone Sulfate
Other
Market segment by Application can be divided into
Alzheimer’S Disease
Amyotrophic Lateral Sclerosis
Parkinson’S Disease
Other
The key market players for global Neurotrophins market are listed below:
Johnson＆Johnson
Lonza Groups
FibroGen
Scil Proteins GmbH
Merck Serono
Scil Proteins GmbH
PeproTech
GE Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurotrophins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurotrophins, with price, sales, revenue and global market share of Neurotrophins from 2019 to 2022.
Chapter 3, the Neurotrophins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurotrophins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neurotrophins market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurotrophins.
Chapter 13, 14, and 15, to describe Neurotrophins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Neurotrophins Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurotrophins Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurotrophins Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Alzheimer’S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson’S Disease
1.3.5 Other
1.4 Global Neurotrophins Market Size & Forecast
1.4.1 Global Neurotrophins Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neurotrophins Sales in Volume (2017-2028)
1.4.3 Global Neurotrophins Price (2017-2028)
1.5 Global Neurotrophins Production Capacity Analysis
1.5.1 Global Neurotrophins Total Production Capacity (2017-2028)
1.5.2 Global Neurotrophins Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neurotrophins Market Drivers
1.6.2 Neurotrophins Market Restraints
1.6.3 Neurotrophins Trends Analysis
2 Manufacturers Profiles
2.1 Johnson＆Johnson
2.1.1 Johnson＆Johnson Details
2.1.2 Johnson＆Johnson Major Business
2.1.3 Johnson＆Johnson Neurotrophins Product and Services
2.1.4 Johnson＆Johnson Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lonza Groups
2.2.1 Lonza Groups Details
2.2.2 Lonza Groups Major Business
2.2.3 Lonza Groups Neurotrophins Product and Services
2.2.4 Lonza Groups Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 FibroGen
2.3.1 FibroGen Details
2.3.2 FibroGen Major Business
2.3.3 FibroGen Neurotrophins Product and Services
2.3.4 FibroGen Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Scil Proteins GmbH
2.4.1 Scil Proteins GmbH Details
2.4.2 Scil Proteins GmbH Major Business
2.4.3 Scil Proteins GmbH Neurotrophins Product and Services
2.4.4 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck Serono
2.5.1 Merck Serono Details
2.5.2 Merck Serono Major Business
2.5.3 Merck Serono Neurotrophins Product and Services
2.5.4 Merck Serono Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Scil Proteins GmbH
2.6.1 Scil Proteins GmbH Details
2.6.2 Scil Proteins GmbH Major Business
2.6.3 Scil Proteins GmbH Neurotrophins Product and Services
2.6.4 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PeproTech
2.7.1 PeproTech Details
2.7.2 PeproTech Major Business
2.7.3 PeproTech Neurotrophins Product and Services
2.7.4 PeproTech Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Neurotrophins Product and Services
2.8.4 GE Healthcare Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Neurotrophins Breakdown Data by Manufacturer
3.1 Global Neurotrophins Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neurotrophins Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neurotrophins
3.4 Market Concentration Rate
3.4.1 Top 3 Neurotrophins Manufacturer Market Share in 2021
3.4.2 Top 6 Neurotrophins Manufacturer Market Share in 2021
3.5 Global Neurotrophins Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neurotrophins Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neurotrophins Market Size by Region
4.1.1 Global Neurotrophins Sales in Volume by Region (2017-2028)
4.1.2 Global Neurotrophins Revenue by Region (2017-2028)
4.2 North America Neurotrophins Revenue (2017-2028)
4.3 Europe Neurotrophins Revenue (2017-2028)
4.4 Asia-Pacific Neurotrophins Revenue (2017-2028)
4.5 South America Neurotrophins Revenue (2017-2028)
4.6 Middle East and Africa Neurotrophins Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Neurotrophins Sales in Volume by Type (2017-2028)
5.2 Global Neurotrophins Revenue by Type (2017-2028)
5.3 Global Neurotrophins Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Neurotrophins Sales in Volume by Application (2017-2028)
6.2 Global Neurotrophins Revenue by Application (2017-2028)
6.3 Global Neurotrophins Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Neurotrophins Sales by Type (2017-2028)
7.2 North America Neurotrophins Sales by Application (2017-2028)
7.3 North America Neurotrophins Market Size by Country
7.3.1 North America Neurotrophins Sales in Volume by Country (2017-2028)
7.3.2 North America Neurotrophins Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Neurotrophins Sales by Type (2017-2028)
8.2 Europe Neurotrophins Sales by Application (2017-2028)
8.3 Europe Neurotrophins Market Size by Country
8.3.1 Europe Neurotrophins Sales in Volume by Country (2017-2028)
8.3.2 Europe Neurotrophins Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Neurotrophins Sales by Type (2017-2028)
9.2 Asia-Pacific Neurotrophins Sales by Application (2017-2028)
9.3 Asia-Pacific Neurotrophins Market Size by Region
9.3.1 Asia-Pacific Neurotrophins Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neurotrophins Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Neurotrophins Sales by Type (2017-2028)
10.2 South America Neurotrophins Sales by Application (2017-2028)
10.3 South America Neurotrophins Market Size by Country
10.3.1 South America Neurotrophins Sales in Volume by Country (2017-2028)
10.3.2 South America Neurotrophins Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neurotrophins Sales by Type (2017-2028)
11.2 Middle East & Africa Neurotrophins Sales by Application (2017-2028)
11.3 Middle East & Africa Neurotrophins Market Size by Country
11.3.1 Middle East & Africa Neurotrophins Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neurotrophins Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Neurotrophins and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neurotrophins
12.3 Neurotrophins Production Process
12.4 Neurotrophins Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neurotrophins Typical Distributors
13.3 Neurotrophins Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Neurotrophins Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neurotrophins Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson＆Johnson Major Business
Table 5. Johnson＆Johnson Neurotrophins Product and Services
Table 6. Johnson＆Johnson Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Lonza Groups Basic Information, Manufacturing Base and Competitors
Table 8. Lonza Groups Major Business
Table 9. Lonza Groups Neurotrophins Product and Services
Table 10. Lonza Groups Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. FibroGen Basic Information, Manufacturing Base and Competitors
Table 12. FibroGen Major Business
Table 13. FibroGen Neurotrophins Product and Services
Table 14. FibroGen Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Scil Proteins GmbH Basic Information, Manufacturing Base and Competitors
Table 16. Scil Proteins GmbH Major Business
Table 17. Scil Proteins GmbH Neurotrophins Product and Services
Table 18. Scil Proteins GmbH Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 20. Merck Serono Major Business
Table 21. Merck Serono Neurotrophins Product and Services
Table 22. Merck Serono Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Scil Proteins GmbH Basic Information, Manufacturing Base and Competitors
Table 24. Scil Proteins GmbH Major Business
Table 25. Scil Proteins GmbH Neurotrophins Product and Services
Table 26. Scil Proteins GmbH Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. PeproTech Basic Information, Manufacturing Base and Competitors
Table 28. PeproTech Major Business
Table 29. PeproTech Neurotrophins Product and Services
Table 30. PeproTech Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Neurotrophins Product and Services
Table 34. GE Healthcare Neurotrophins Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Neurotrophins Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Neurotrophins Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Neurotrophins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Neurotrophins Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Neurotrophins Production Site of Key Manufacturer
Table 40. Neurotrophins New Entrant and Capacity Expansion Plans
Table 41. Neurotrophins Mergers & Acquisitions in the Past Five Years
Table 42. Global Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 43. Global Neurotrophins Sales by Region (2023-2028) & (K Units)
Table 44. Global Neurotrophins Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Neurotrophins Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 47. Global Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 48. Global Neurotrophins Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Neurotrophins Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Neurotrophins Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Neurotrophins Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 53. Global Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 54. Global Neurotrophins Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Neurotrophins Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Neurotrophins Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Neurotrophins Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 59. North America Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 60. North America Neurotrophins Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Neurotrophins Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 63. North America Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 64. North America Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 65. North America Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 66. Europe Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 67. Europe Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 68. Europe Neurotrophins Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Neurotrophins Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 71. Europe Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 72. Europe Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 73. Europe Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Neurotrophins Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Neurotrophins Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Neurotrophins Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 82. South America Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 83. South America Neurotrophins Sales by Country (2023-2028) & (K Units)
Table 84. South America Neurotrophins Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Neurotrophins Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 87. South America Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 88. South America Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 89. South America Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Neurotrophins Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Neurotrophins Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Neurotrophins Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Neurotrophins Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Neurotrophins Sales by Application (2023-2028) & (K Units)
Table 98. Neurotrophins Raw Material
Table 99. Key Manufacturers of Neurotrophins Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Neurotrophins Typical Distributors
Table 103. Neurotrophins Typical Customers
List of Figures
Figure 1. Neurotrophins Picture
Figure 2. Global Neurotrophins Revenue Market Share by Type in 2021
Figure 3. Nerve Growth Factor
Figure 4. Brain-Derived Neurotrophic Factor
Figure 5. Dehydroepiandrosterone Sulfate
Figure 6. Other
Figure 7. Global Neurotrophins Revenue Market Share by Application in 2021
Figure 8. Alzheimer'S Disease
Figure 9. Amyotrophic Lateral Sclerosis
Figure 10. Parkinson'S Disease
Figure 11. Other
Figure 12. Global Neurotrophins Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Neurotrophins Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Neurotrophins Sales (2017-2028) & (K Units)
Figure 15. Global Neurotrophins Price (2017-2028) & (US$/Unit)
Figure 16. Global Neurotrophins Production Capacity (2017-2028) & (K Units)
Figure 17. Global Neurotrophins Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Neurotrophins Market Drivers
Figure 19. Neurotrophins Market Restraints
Figure 20. Neurotrophins Market Trends
Figure 21. Global Neurotrophins Sales Market Share by Manufacturer in 2021
Figure 22. Global Neurotrophins Revenue Market Share by Manufacturer in 2021
Figure 23. Neurotrophins Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Neurotrophins Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Neurotrophins Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Neurotrophins Sales Market Share by Region (2017-2028)
Figure 27. Global Neurotrophins Revenue Market Share by Region (2017-2028)
Figure 28. North America Neurotrophins Revenue (2017-2028) & (USD Million)
Figure 29. Europe Neurotrophins Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Neurotrophins Revenue (2017-2028) & (USD Million)
Figure 31. South America Neurotrophins Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Neurotrophins Revenue (2017-2028) & (USD Million)
Figure 33. Global Neurotrophins Sales Market Share by Type (2017-2028)
Figure 34. Global Neurotrophins Revenue Market Share by Type (2017-2028)
Figure 35. Global Neurotrophins Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Neurotrophins Sales Market Share by Application (2017-2028)
Figure 37. Global Neurotrophins Revenue Market Share by Application (2017-2028)
Figure 38. Global Neurotrophins Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Neurotrophins Sales Market Share by Type (2017-2028)
Figure 40. North America Neurotrophins Sales Market Share by Application (2017-2028)
Figure 41. North America Neurotrophins Sales Market Share by Country (2017-2028)
Figure 42. North America Neurotrophins Revenue Market Share by Country (2017-2028)
Figure 43. United States Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Neurotrophins Sales Market Share by Type (2017-2028)
Figure 47. Europe Neurotrophins Sales Market Share by Application (2017-2028)
Figure 48. Europe Neurotrophins Sales Market Share by Country (2017-2028)
Figure 49. Europe Neurotrophins Revenue Market Share by Country (2017-2028)
Figure 50. Germany Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Neurotrophins Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Neurotrophins Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Neurotrophins Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Neurotrophins Revenue Market Share by Region (2017-2028)
Figure 59. China Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Neurotrophins Sales Market Share by Type (2017-2028)
Figure 66. South America Neurotrophins Sales Market Share by Application (2017-2028)
Figure 67. South America Neurotrophins Sales Market Share by Country (2017-2028)
Figure 68. South America Neurotrophins Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Neurotrophins Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Neurotrophins Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Neurotrophins Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Neurotrophins Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Neurotrophins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Neurotrophins in 2021
Figure 80. Manufacturing Process Analysis of Neurotrophins
Figure 81. Neurotrophins Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のニューロトロフィン市場2022年：神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他(Global Neurotrophins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のアレルギー薬市場2022年：錠剤、液剤
  • 世界のニモツズマブ市場2022年：0.5ML、 1ML、 その他
  • 世界の流動性止血鉗子市場2022年：豚ゼラチン、牛ゼラチン
  • 世界の眼窩周囲インプラント市場2022年：CHA、 MCI
  • 世界のシースカテーテル市場2022年：大腿動脈シース、橈骨動脈シース、その他